Why Africa’s push to make vaccines should look further than COVID-19

Africa’s segmented markets, and often small economies, are at odds with the fact that vaccines are mostly produced in large quantities to …

How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers

Compulsory licensing might be the answer  

Nigeria at sixes and sevens on COVID-19 vaccine rollout

Nigeria plans to vaccinate 40% of its citizens before end of 2021 and 70% by end of 2022

Lateral Thoughts: A paradigm change in clinical trials

The rich and famous are clamouring to get the ‘experimental’ COVID-19 vaccine

COVID-19 shows why African data is key for the continent’s response to pandemics

African public health practitioners have amassed a wealth of experience of managing epidemics

Simply put: COVID-19 vaccine exploration

Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: What’s known so far

Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines

Low trust in authorities affects vaccine uptake: Evidence from 22 African countries

Nearly half of the world’s unvaccinated and under-vaccinated children live in Africa

Lateral Thoughts: Healthy ageing was never so attractive

Accessing COVID-19 vaccine is logistically difficult for the old and sick  

COVID-19 vaccines work well with all body weights BUT underweight, obesity remain risk factors

A group of UK researchers compare how those vaccinated from across various categories fared against the novel coronavirus  

Want to know about COVID-19 vaccine rollouts in Africa? Click on a country here and find out

In the 29 low-income countries, only 3 out of 100 people have received one dose of the vaccine 

A granular look at UK’s COVID-19 ‘red list’ shows why it’s deeply flawed

Sudan is on the red list whereas South Sudan is not.  

India is preparing for another COVID-19 surge but low vaccine coverage leaves it vulnerable

So far less than 10% of the population is fully vaccinated

What are India’s options for a booster dose of COVID-19 vaccine

Hyderabad-based Biological E’s Corbevax and SII’s Covovax, both of which are protein-based vaccines, are India’s best bet for a …

Why vaccine doses differ for babies, kids, teens and adults: An immunologist explains

As time passes, your immune system matures through different stages, much the way you advanced from crawling to standing, walking and running

Rich countries must share their vaccines with poor ones quickly: WHO panel

Vaccine distribution to low-income countries falls short of 1 billion target, former panel leaders, Ellen Johnson Sirleaf and Helen Clark, said

Back to school? May have unimaginable, uncontrollable consequences on health

Instead of reopening schools, educationists should research how to communicate efficiently in online classes   

COVID-19 herd immunity? It’s not going to happen, so what next?

The only sustainable solution is to learn to live with the virus.  

Gujarat's pastoral communities struggling for awareness, infrastructure to combat second COVID-19 wave

The nomadic pastoral communities cannot afford to remain in their houses even during a pandemic 

COVID-19 vaccination has turned into a ‘battle of the brands’. But not everyone’s buying it

The best thing we can do is to tone down the brand narrative within the significant constraints we face. All COVID-19 vaccines are safe and effective

South African case study sheds light on how vaccine manufacturing can be developed

Additional costs made it harder for local companies to break even and recover working capital

Interested in vaccine rollouts across Africa? Here’s a map to guide you

A map that will be updated daily, showing how many people have been vaccinated across the continent

COVID-19 vaccine: 74% scheduled health workers didn't get second shot

Less than half the scheduled workers have received the first shot

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Important questions remain: It’s unclear how long protection will last and if the vaccine protects against severe disease

What we know so far about COVID-19 vaccine: A comprehensive guide by academic experts

With so much at stake, it’s not surprising that COVID-19 vaccines have become a public and political obsession. The good news is that …